Craft

Thorne

Stock Price

$10.2

2023-10-16

Market Capitalization

$550.9 M

2023-10-16

Revenue

$228.7 M

FY, 2022

Thorne Summary

Company Summary

Overview
Thorne is a company that provides at-home biomarker tests and digestive enzyme supplements. It develops the Onegvity Health Intelligence platform and offers health tests such as biological age, fertility, gut health, menopause, sleep, stress, thyroid, vitamin D, and weight management. The company also recommends health plans and supplements based on test results.
Type
Public
Status
Active
Founded
2010
HQ
New York, NY, US | view all locations
Website
https://www.thorne.com/
Cybersecurity rating
Sectors

Key People

  • Paul Jacobson

    Paul Jacobson, Chairman and Chief Executive Officer

  • Tom McKenna

    Tom McKenna, Chief Operating Officer

  • Michelle Crow

    Michelle Crow, Chief Marketing Officer

  • Bodi Zhang

    Bodi Zhang, Chief Strategy Officer

Operating MetricsView all

Patents (US)

1

May, 2020

Product Types

2

May, 2020

Products (Liver & Detox)

33

May, 2020

LocationsView all

2 locations detected

  • New York, NY HQ

    United States

    152 W 57th St 21st Floor

  • Summerville, SC

    United States

    620 Omni Industrial Blvd

Thorne Financials

Summary Financials

Revenue (Q2, 2023)
$72.7M
Gross profit (Q2, 2023)
$40.6M
Net income (Q2, 2023)
$4.3M
Cash (Q2, 2023)
$17.1M
EBIT (Q2, 2023)
$6.6M
Enterprise value
$608.5M

Footer menu